# A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241)

> **NCT01471340** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 11744 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Mometasone Furoate/Formoterol MDI 100/5 mcg
- **DRUG:** Mometasone Furoate/Formoterol MDI 200/5 mcg
- **DRUG:** Mometasone Furoate MDI 100 mcg
- **DRUG:** Mometasone Furoate MDI 200 mcg
- **DRUG:** Albuterol 90 mcg /salbutamol 100 mcg HFA MDI
- **DRUG:** Prednisone/prednisolone

## Key facts

- **NCT ID:** NCT01471340
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-09
- **Primary completion:** 2016-11-30
- **Final completion:** 2016-11-30
- **Target enrollment:** 11744 (ACTUAL)
- **Last updated:** 2024-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01471340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01471340, "A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01471340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*